Determining the specificity of vesicle traffic at the Golgi apparatus

确定高尔基体囊泡运输的特异性

基本信息

  • 批准号:
    BB/X006859/1
  • 负责人:
  • 金额:
    $ 69.27万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

The cells that make up our organs and tissues are comprised of internal compartments, called organelles, that have distinct compositions and functions. Most organelles contain fat-like molecules called lipids that make a limiting membrane to separate the organelle contents from the rest of the cell, as well as many types of proteins. The function of organelles requires the delivery of new materials and the exchange of materials with other organelles in the cell. Transport of proteins and lipids between organelles is mediated by small spherical carriers called vesicles, which bud off one compartment and bind to and fuse with their destination compartment to deliver their contents. This process, which is conserved in all plants and animals, is essential for life, and when defective can result in a large number of diseases in humans. It is also exploited by pathogenic bacteria and viruses during their life cycle. Vesicle transport is highly specific, such that vesicles are recognized at the destination compartment in a selective manner, which ensures they deliver their contents to the correct place. Although vesicle transport has been studied for decades, we still lack a good understanding of how vesicle recognition occurs.The Golgi apparatus is a major transport hub in the cell. It receives vesicles from other organelles, and also moves cargo between its own sub-compartments in vesicles. Its major function is to sort cargo for distribution, and to modify it so it matures correctly. Vesicle recognition at the Golgi is mediated by long proteins called golgins, which are act like tentacles to capture, or tether, vesicles at their ends. Previous work has shown that golgins act in a selective manner to tether vesicles, thereby contributing to the specificity of vesicle transport at the Golgi. However, what they recognise on vesicles is not known. It is also not known whether the golgins have overlapping specificity in vesicle recognition. This study will address these outstanding questions, focussing on the golgins that mediate transport within the Golgi, which is critical for the function of this organelle. Our preliminary data suggests that lipids on the vesicle surface dictate the specificity of vesicle transport at the Golgi through selective recognition by the golgins. To test this hypothesis, we will investigate the lipid binding specificity of the golgins, using purified lipid vesicles and golgins, combined with unbiased lipid identification techniques, and determine the features of the golgins that bind to lipids. Subsequently, we will determine the importance of golgin-vesicle lipid interaction in the transport and modification of cargo proteins at the Golgi apparatus. This will be achieved using gene editing techniques to alter the golgins so they can no longer bind vesicle lipids, and effects upon cargo transport assessed using established assays. Cargo modification will be also assessed using established methods to measure the amount and composition of sugars added to the cargo proteins in the Golgi, which is highly dependent on vesicle transport rates at this organelle. To assess the importance of golgin binding to vesicle lipids in a more physiological context, we will perform similar experiments in the nematode worm C. elegans. Effects upon development, viability, tissue formation and function, and ageing, will be assessed alongside analysis of the Golgi in different cell types. Because of the genetic tractability of this model, we will also be able to knock-out or modify the golgins in different combinations to assess the extent of overlapping specificity and functional redundancy between these proteins, and hence of vesicle transport at the Golgi. The work will be important for our understanding of vesicle transport, and specifically in how the specificity of vesicle transport is achieved, which represents a major unanswered question in the field.
构成我们器官和组织的细胞由内部隔室组成,称为细胞器,具有不同的组成和功能。大多数细胞器含有脂肪样分子,称为脂质,它们构成限制膜,将细胞器内容物与细胞的其他部分以及许多类型的蛋白质分开。细胞器的功能需要新物质的传递以及与细胞内其他细胞器的物质交换。蛋白质和脂质在细胞器之间的转运是由称为囊泡的小球形载体介导的,囊泡从一个隔室中出芽,并与其目的隔室结合并融合以递送其内容物。这一过程在所有植物和动物中都是保守的,是生命所必需的,如果有缺陷,可能导致人类大量疾病。它也被致病细菌和病毒在其生命周期中利用。囊泡运输是高度特异性的,使得囊泡以选择性的方式在目的地隔室被识别,这确保它们将其内容物递送到正确的位置。尽管人们对囊泡运输的研究已经有几十年的历史,但是对于囊泡识别的过程仍然缺乏深入的了解。它从其他细胞器接收囊泡,并在囊泡中的子隔室之间移动货物。它的主要功能是对货物进行分类以进行分配,并对其进行修改以使其正确成熟。囊泡在高尔基体的识别是由一种叫做golgins的长蛋白介导的,这种长蛋白就像触角一样捕获或拴系囊泡的末端。以前的工作表明,高尔基体以选择性的方式拴系囊泡,从而有助于囊泡在高尔基体运输的特异性。然而,它们在囊泡上识别什么尚不清楚。也不知道golgins是否在囊泡识别中具有重叠特异性。这项研究将解决这些悬而未决的问题,集中在高尔基体内,这是这个细胞器的功能至关重要的介导运输的golgins。我们的初步数据表明,囊泡表面的脂质决定了囊泡运输的特异性,通过选择性识别的高尔基体。为了验证这一假设,我们将调查的golgins的脂质结合特异性,使用纯化的脂质囊泡和golgins,结合无偏的脂质鉴定技术,并确定的golgins结合脂质的功能。随后,我们将确定在高尔基体的货物蛋白的运输和修改的重要性,高尔基体囊泡脂质相互作用。这将使用基因编辑技术来改变golgins,使它们不再结合囊泡脂质,并使用已建立的测定评估对货物运输的影响。货物修改也将使用已建立的方法来评估,以测量添加到高尔基体中的货物蛋白的糖的量和组成,这是高度依赖于囊泡运输率在这个细胞器。为了评估高尔基体结合囊泡脂质的重要性,我们将在线虫C。优美的对发育、活力、组织形成和功能以及衰老的影响将与不同细胞类型中高尔基体的分析一起进行评估。由于该模型的遗传易处理性,我们也将能够敲除或修饰不同组合的高尔基体,以评估这些蛋白质之间的重叠特异性和功能冗余的程度,从而评估高尔基体的囊泡运输。这项工作对于我们理解囊泡运输,特别是囊泡运输的特异性是如何实现的,这是该领域一个尚未回答的主要问题,将是重要的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin Lowe其他文献

High prevalence of early repolarization in the pediatric relatives of Sudden Arrhythmic Death Syndrome (SADS) victims and in normal controls
心律失常性死亡综合症 (SADS) 患者的儿科亲属和正常对照中早期复极的发生率较高
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. McCorquodale;R. Poulton;J. Hendry;G. Norrish;E. Field;Sarah;Mead;Martin Lowe;J. Kaski
  • 通讯作者:
    J. Kaski
PO-04-149 strongAHEAD OF THE CURVE – EXPERIENCE FROM THE UK’S FIRST DEDICATED SPECIALIST CRM CLINIC FOR ACHD PATIENTS/strong
PO-04-149 领先于曲线——来自英国第一家专门为 ACHD 患者设立的专业 CRM 诊所的经验
  • DOI:
    10.1016/j.hrthm.2023.03.1273
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Holly L. Daw;Ciaran Goswell;Charles Butcher;Jeremy Kalindjian;Bruna C. Di Nubila;Vinit Sawhney;Martin Lowe;Filip R. Zemrak;Vivienne A. Ezzat
  • 通讯作者:
    Vivienne A. Ezzat
Glutamate Release from Guinea‐Pig Synaptosomes: Stimulation by Reuptake‐Induced Depolarization
豚鼠突触体中谷氨酸的释放:再摄取诱导的去极化的刺激
  • DOI:
    10.1111/j.1471-4159.1989.tb07296.x
  • 发表时间:
    1989
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    H. McMahon;A. Barrie;Martin Lowe;D. Nicholls
  • 通讯作者:
    D. Nicholls
Signalling for secretion
分泌信号
  • DOI:
    10.1038/ncb0905-851
  • 发表时间:
    2005-09-01
  • 期刊:
  • 影响因子:
    19.100
  • 作者:
    Yashoda Ghanekar;Martin Lowe
  • 通讯作者:
    Martin Lowe
PO-01-048 strongFACTORS INFLUENCING SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SCREENING SUCCESS IN PAEDIATRIC POPULATION: A TERTIARY HOSPITAL EXPERIENCE/strong
影响儿科人群皮下植入式心脏复律除颤器筛查成功的强因素:一家三级医院的经验
  • DOI:
    10.1016/j.hrthm.2023.03.697
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Alanna Morrison;Sophie Marshall;Stacey James;Charles Butcher;Eleanor Thompson;Martin Lowe;Jasveer S. Mangat;Abdualrahman Alkanhal
  • 通讯作者:
    Abdualrahman Alkanhal

Martin Lowe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martin Lowe', 18)}}的其他基金

Understanding and treating neurogenetic conditions related to the Kennedy pathway
了解和治疗与肯尼迪通路相关的神经遗传疾病
  • 批准号:
    MR/Y014251/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Coordination of membrane traffic in the early secretory pathway
早期分泌途径中膜运输的协调
  • 批准号:
    BB/S014799/1
  • 财政年份:
    2019
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
A new role for intermediate filaments in the secretory pathway
中间丝在分泌途径中的新作用
  • 批准号:
    BB/T000945/1
  • 财政年份:
    2019
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Mechanisms of endocytic recycling in the renal proximal tubule
肾近曲小管内吞再循环机制
  • 批准号:
    BB/N000641/1
  • 财政年份:
    2016
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Dissecting the function of GORAB, the protein mutated in Geroderma osteodysplastica
剖析 GORAB 的功能,GORAB 是骨发育不良中突变的蛋白质
  • 批准号:
    MR/N000366/1
  • 财政年份:
    2015
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
The role of OCRL1 in endocytic membrane traffic
OCRL1在内吞膜运输中的作用
  • 批准号:
    MR/K000810/1
  • 财政年份:
    2013
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Dissecting the roles of ZFPL1 and GMAP210 in Golgi biogenesis and membrane traffic
剖析 ZFPL1 和 GMAP210 在高尔基体生物发生和膜运输中的作用
  • 批准号:
    BB/I007717/1
  • 财政年份:
    2011
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
A Manchester-Beijing Strategic Parntership in Molecular Life Sciences
曼彻斯特-北京分子生命科学战略合作伙伴关系
  • 批准号:
    BB/H531600/1
  • 财政年份:
    2010
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Mitotic regulation of the Golgi apparatus- the role of the ARF nucleotide exchange factor GBF1
高尔基体的有丝分裂调节——ARF核苷酸交换因子GBF1的作用
  • 批准号:
    BB/F005628/1
  • 财政年份:
    2008
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Molecular organisation of the secretory and endocytic pathways
分泌和内吞途径的分子组织
  • 批准号:
    G0501725/1
  • 财政年份:
    2006
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant

相似国自然基金

背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
  • 批准号:
    82371224
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
多盘科单殖吸虫宿主特异性及其与无尾两栖类宿主协同进化关系研究
  • 批准号:
    30960049
  • 批准年份:
    2009
  • 资助金额:
    23.0 万元
  • 项目类别:
    地区科学基金项目
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
  • 批准号:
    30971223
  • 批准年份:
    2009
  • 资助金额:
    31.0 万元
  • 项目类别:
    面上项目

相似海外基金

Surface exosome integrin profiling to predict organotropic metastasis of breast cancer
表面外泌体整合素分析预测乳腺癌的器官转移
  • 批准号:
    10654221
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection
封装 CRISPR 机制的细胞外囊泡用于治疗 SARS-CoV-2 感染
  • 批准号:
    10655147
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers
纳米级低聚物诱导的纳米膜调节
  • 批准号:
    10790511
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Comparison of direct and indirect magnetic resonance imaging of myelin in Alzheimer's disease
阿尔茨海默病髓磷脂直接和间接磁共振成像的比较
  • 批准号:
    10680319
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Molecular mechanism of membrane association of Bruton's Tyrosine Kinase
布鲁顿酪氨酸激酶膜缔合的分子机制
  • 批准号:
    10604872
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Dual protease activated peptides for specific targeting
用于特异性靶向的双蛋白酶激活肽
  • 批准号:
    10680341
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Affinity purification of cross-ß fibrils using immobilized thioflavin
使用固定化硫代黄素对交叉原纤维进行亲和纯化
  • 批准号:
    10646061
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Increasing the Complexity of Microtubule-based transport: Cargo adaptors and Hitchhiking on Vesicles.
增加基于微管的运输的复杂性:货物适配器和囊泡搭便车。
  • 批准号:
    10713449
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Targeting Cholinergic Deficits with Retinoic Acid after TBI
使用视黄酸治疗 TBI 后的胆碱能缺陷
  • 批准号:
    10741924
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
A nanosized magnetic particle system for fast and efficient neuronal extracellular vesicle enrichment from plasma
一种纳米磁性粒子系统,用于从血浆中快速有效地富集神经元细胞外囊泡
  • 批准号:
    10820640
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了